Brief: TELA Bio Q1 Revenue USD 16.603 Million Vs. IBES Estimate USD 16.3 Million
09/05/2024 21:05
May 09 (Reuters) - TELA Bio Q1 gross profit USD 11.336 million. * Q1 basic EPS USD -0.23 * Q1 operating expenses USD 23.742 million * Q1 income from operations USD -4.826 million * Q1 net income USD -5.661 million * outlook FY revenue USD 74.5-76.5 million
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants